All News

Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems

Kalamazoo, Michigan – December 19, 2016 – Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as “Stryker Orthopaedics”), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations reached an agreement to compensate additional eligible U.S. patients […]

Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems

Kalamazoo, Michigan – December 19, 2016 – Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as “Stryker Orthopaedics”), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations reached an agreement to compensate additional eligible U.S. patients […]

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2016

WARSAW, Ind., Dec. 19, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2016. The cash dividend of $0.24 per share will be paid on or about January 27, […]

Stem cell ‘living bandage’ for knee injuries trialed in humans

December 16, 2016 – University of Liverpool A ‘living bandage’ made from stem cells, which could revolutionise the treatment and prognosis of a common sporting knee injury, has been trialed in humans for the first time by scientists at the Universities of Liverpool and Bristol. Meniscal tears are suffered by over one million people a year […]

Kuros Acquires Xpand to Form Orthobiologics Firm with Bone Graft Substitute

December 19, 2016 Kuros Biosciences is to acquire Xpand Biotechnology by way of a share-swapping deal structured as an exchange of all Xpand shares for up to 2.105 million new Kuros shares. A total of 1.36 million Kuros shares will be issued immediately upon the deal closing. Another 0.74 million Kuros shares will be issued […]

Amedica Announces Positive Scientific Data and Re-files FDA Submission

SALT LAKE CITY, UT — (Marketwired) — 12/19/16 — Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced encouraging results from a recent study showing rapid bone growth into porous silicon nitride. Explants of the company’s porous silicon nitride from a large-animal model demonstrated bone healing […]

Safe Orthopaedics Receives CE Mark for a New Implant to Treat Vertebral Fractures

December 16, 2016 ERAGNY-SUR-OISE, France–(BUSINESS WIRE)–Regulatory News: SAFE ORTHOPAEDICS (FR0012452746 – SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments, today announces that it has received CE Mark for a new version of its patented Oak screw used to treat thoracic vertebral fractures. Previously, 7.5 mm, 6.5 mm and 5.5 mm diameter versions […]

Predictive Technology Group, Inc. (PRED) Announces Notice of US Patent Allowance for Method for Treating Patients with Genetic Spinal Deformities and Syndromes

SALT LAKE CITY, UT–(Marketwired – December 16, 2016) – Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a fundamental patent application — US20160296671 -that covers the practice of administering “ANY” spine deformation therapeutics to a patient having […]

Vericel Corporation Prices $17 Million Public Offering of Common Stock

CAMBRIDGE, Mass., Dec. 16, 2016 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced the pricing of its previously announced underwritten public offering of 6,200,000 shares of its common stock, offered at a price to the public of […]

New Medical Device Registration Requirements Issued in South Africa

December 14, 2016 by Stewart Eisenhart   EMERGO SUMMARY OF KEY POINTS: New South African registration requirements for medical devices and IVDs appear to have taken immediate effect from December 9, 2016. Registration will initially be required only for devices participating in South Africa’s public tender system. The Medicines Control Council (MCC) will continue requiring […]

© 2025 MedDeviceJobs.com | Powered by Careerleaf
v.4.6.7-9-gdb70438